Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Nanfang Hospital Southern Medical University has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This 1 matter is assigned to 1 distinct examiner and is located in 1 distinct art unit. The current prosecution profile is very limited, with only 1 active matter currently pending before the patent office. This concentration simplifies the management of the pending workload but makes the outcome of this 1 action critical for the university's biotech filings.
DUFFY, PATRICIA ANN is the busiest examiner for this portfolio, holding the 1 pending office action. With only 1 distinct examiner and 1 distinct art unit involved, the university's immediate patent strategy is focused entirely on this 1 interaction. This allows for a very specific prosecution strategy directed at DUFFY, PATRICIA ANN within a single technical division. Practitioners should ensure that the response to this 1 pending office action is robust, as it represents the entirety of the university's current activity in this technology area.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| DUFFY, PATRICIA ANN | 1 | 52.9% | +33.9% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18627441 | Lacticaseibacillus Rhamnosus DY801 and Application Thereof | DUFFY, PATRICIA ANN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18627441 | Lacticaseibacillus Rhamnosus DY801 and Application Thereof | DUFFY, PATRICIA ANN | — |
| Art Unit | Apps |
|---|---|
| 1645 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18627441 | Lacticaseibacillus Rhamnosus DY801 and Application Thereof | DUFFY, PATRICIA ANN | 1645 | §102§112 | Final Rejection | — | Pending | Apr 04, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialNanfang Hospital Southern Medical University has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Patricia Ann Duffy has the most, with 1 of Nanfang Hospital Southern Medical University's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.